Singular Genomics Systems Inc (OMIC)
15.49
-0.02
(-0.13%)
USD |
NASDAQ |
Sep 27, 16:00
15.60
+0.11
(+0.71%)
Pre-Market: 20:00
Singular Genomics Systems Research and Development Expense (Annual): 47.76M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.76M |
| December 31, 2022 | 46.20M |
| December 31, 2021 | 32.66M |
| Date | Value |
|---|---|
| December 31, 2020 | 21.25M |
| December 31, 2019 | 10.48M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
10.48M
Minimum
2019
47.76M
Maximum
2023
31.67M
Average
32.66M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Bruker Corp | 294.80M |
| Azenta Inc | 33.96M |
| Harvard Bioscience Inc | 11.76M |
| Bionano Genomics Inc | 54.03M |
| Akoya Biosciences Inc | 21.89M |